Recombinant Human Alpha 1-Microglobulin Protein (HEK293)，His

Alpha 1-Microglobulin (A1M) is a small plasma protein that plays a crucial role in various physiological processes, including immune response, as well as protecting tissues from oxidative stress and inflammation. Its potential therapeutic applications have garnered significant interest in recent years, particularly due to its protective properties against kidney damage and other organ injuries. Research has shown that A1M can act as a scavenger for free radicals, thereby mitigating cellular damage in conditions such as sepsis, acute kidney injury, and chronic inflammatory diseases. The recombinant production of A1M has enabled researchers to study its structure-function relationships more effectively and to explore its potential as a biotherapeutic agent. Advances in recombinant DNA technology have facilitated the large-scale synthesis of A1M, providing a consistent and homogeneous product for both experimental and clinical applications. Moreover, ongoing studies are investigating the immunomodulatory effects of A1M, along with its ability to improve outcomes in transplantation and enhance tissue regeneration. Overall, the exploration of recombinant A1M represents a promising avenue for developing new therapeutic strategies to combat various diseases associated with oxidative stress and inflammation.